INSPRA Side Effects

7017661-3 | Cardiac Pacemaker Insertion
on Sep 17, 2010 Female patient from UNITED STATES , weighting 149.9 lb, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?), osteoporosis (What is osteoporosis?) and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac pacemaker insertion. Inspra dosage: 50 Mg, 1x/day. During the same period patient was treated with METOPROLOL (75 Mg, 2x/day) (View Metoprolol Review and Metoprolol Label ), WARFARIN SODIUM (2 Mg, 1x/day) (View Warfarin Sodium Review and Warfarin Sodium Label ), LISINOPRIL (5 Mg, 1x/day) (View Lisinopril Review and Lisinopril Label ), CENTRUM SILVER (Unk) (View Centrum Silver Review and Centrum Silver Label ), CALCIUM (600 Mg, Unk) (View Calcium Review and Calcium Label ), AMIODARONE (Unk) (View Amiodarone Review and Amiodarone Label ).

6965125-5 | Hyperkalaemia, Renal Failure
Patient was taking Inspra (View Usage). Patient had the following side effects: hyperkalaemia, renal failure on Aug 25, 2010 from FRANCE Additional patient health information: Female patient , 75 years of age, . Inspra dosage: 25 Mg, 2x/day. Patient was hospitalized.

6896510-8 | Bone Pain, Dizziness, Fatigue, Headache, Limb Discomfort, Nausea
Adverse event was reported on Mar 10, 2009 by a Female patient taking Inspra (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with hypertension, glaucoma (What is glaucoma?) and. Location: UNITED STATES , weighting 148.0 lb, After Inspra was administered, patient had the following side effects: bone pain, dizziness (What is dizziness?), fatigue, headache (What is headache?), limb discomfort, nausea (What is nausea?). During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), ANTIGLAUCOMA PREPARATIONS AND MIOTICS (Unk) (View Antiglaucoma Preparations And Miotics Review and Antiglaucoma Preparations And Miotics Label ).

6896360-2 | Blood Pressure Inadequately Controlled, Fluid Retention, Headache, Weight Increased
on Jan 14, 2009 Female patient from UNITED STATES , weighting 150.0 lb, was diagnosed with hypertension and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, fluid retention, headache (What is headache?), weight increased. Inspra dosage: . During the same period patient was treated with TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LASIX (View Lasix Review and Lasix Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).


6892687-9 | Alopecia, Hair Growth Abnormal, Hirsutism, Hypertension, Swelling Face
on Aug 15, 2008 Female patient from UNITED STATES , weighting 240.1 lb, was diagnosed with hypertension and was treated with Inspra (View Usage). Patient had the following side effects: alopecia, hair growth abnormal, hirsutism, hypertension, swelling face. Inspra dosage: Daily: Everyday. During the same period patient was treated with VALSARTAN AND HYDROCHLOROTHIAZIDE (320/25 Mg: 320/25,daily: Everyday) (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), COREG (Bid: Everyday) (View Coreg Review and Coreg Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6892683-1 | Blood Potassium Decreased, Hypertension
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: blood potassium decreased, hypertension on Oct 16, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 190.0 lb, was diagnosed with blood aldosterone increased, hypertension, blood potassium decreased and. Inspra dosage: . During the same period patient was treated with STATINS (View Statins Review and Statins Label ).

6892554-0 | Abdominal Distension, Abdominal Pain Upper, Erectile Dysfunction
Adverse event was reported on Jun 27, 2008 by a Male patient taking Inspra (View Usage) (Dosage: ) was diagnosed with primary hyperaldosteronism, hyperadrenalism and. Location: UNITED STATES , weighting 170.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, abdominal pain upper, erectile dysfunction (What is erectile dysfunction?). During the same period patient was treated with NIACIN (View Niacin Review and Niacin Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6891844-5 | Erectile Dysfunction, Unevaluable Event
on Nov 01, 2007 Male patient from UNITED STATES , weighting 185.4 lb, was diagnosed with blood aldosterone abnormal and was treated with Inspra (View Usage). Patient had the following side effects: erectile dysfunction (What is erectile dysfunction?), unevaluable event. Inspra dosage: . During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), NORVASC (View Norvasc Review and Norvasc Label ), TENORMIN (View Tenormin Review and Tenormin Label ), NIACIN (View Niacin Review and Niacin Label ), SYNTHROID (View Synthroid Review and Synthroid Label ).

6891648-3 | Disorientation, Malaise
on Sep 10, 2007 Female patient from UNITED STATES , weighting 151.3 lb, was diagnosed with cardiac failure congestive and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: disorientation, malaise. Inspra dosage: . During the same period patient was treated with REVATIO (View Revatio Review and Revatio Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), CUMADIN (View Cumadin Review and Cumadin Label ), NEXIUM (View Nexium Review and Nexium Label ), AVAPRO (View Avapro Review and Avapro Label ).

6768395-1 | Blister, Depressed Mood, Eosinophilia, Fear, Glycosylated Haemoglobin Increased, Hyperglycaemia, Insomnia, Myalgia, Vitamin D Deficiency
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blister, depressed mood, eosinophilia, fear, glycosylated haemoglobin increased, hyperglycaemia, insomnia, myalgia, vitamin d deficiency on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , weighting 160.0 lb, was diagnosed with cardiac failure congestive and. Inspra dosage: Unk. During the same period patient was treated with LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), COREG (Unk) (View Coreg Review and Coreg Label ), LASIX (Unk) (View Lasix Review and Lasix Label ).

6763822-8 | Blood Creatinine Increased, Device Occlusion
Adverse event was reported on May 30, 2010 by a Male patient taking Inspra (View Usage) (Dosage: ) . Location: GERMANY , 60 years of age, Patient had the following side effects: blood creatinine increased, device occlusion. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6728643-0 | Liver Function Test Abnormal
on May 06, 2010 Male patient from GERMANY , 76 years of age, weighting 163.1 lb, was diagnosed with cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: liver function test abnormal. Inspra dosage: 25 Mg, 1x/day. During the same period patient was treated with METOPROLOL SUCCINATE (1 Df, 2x/day) (View Metoprolol Succinate Review and Metoprolol Succinate Label ), RANITIDINE (300 Mg, 1x/day) (View Ranitidine Review and Ranitidine Label ), LASIX (20 Mg, 1x/day) (View Lasix Review and Lasix Label ).

6709524-5 | Gamma-glutamyltransferase Increased
on Apr 23, 2010 Male patient from GERMANY , 76 years of age, was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: gamma-glutamyltransferase increased. Inspra dosage: 25 Mg, 1x/day.

6693929-5 | Haemorrhage Urinary Tract, Hypotension, Renal Failure Acute
Patient was taking Inspra (View Usage). Patient had the following side effects: haemorrhage urinary tract, hypotension, renal failure acute on Apr 13, 2010 from GERMANY Additional patient health information: Male patient , 70 years of age, weighting 167.6 lb, was diagnosed with cardiac failure, coronary artery disease (What is coronary artery disease?), hypertension, cardiac pacemaker insertion, oedema peripheral and. Inspra dosage: 25 Mg, 1x/day. During the same period patient was treated with ACETYLSALICYLIC ACID (100 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), AQUAPHOR TABLET (10 Mg, 1x/day) (View Aquaphor Tablet Review and Aquaphor Tablet Label ), CLEXANE (80 Mg, 2x/day) (View Clexane Review and Clexane Label ), FURORESE (25 Mg, 2x/day) (View Furorese Review and Furorese Label ), RAMIPRIL (2.5 Mg, 1x/day) (View Ramipril Review and Ramipril Label ), BISOPROLOL (2.5 Mg, 1x/day) (View Bisoprolol Review and Bisoprolol Label ), DIGITOXIN (0.07 Mg, 1x/day) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6579957-9 | Renal Failure
Adverse event was reported on Feb 01, 2010 by a Male patient taking Inspra (View Usage) (Dosage: 25 Mg, Daily) was diagnosed with cardiac failure, oedema due to cardiac disease and. Location: SWEDEN , 84 years of age, After Inspra was administered, patient had the following side effects: renal failure. During the same period patient was treated with ENALAPRIL MALEATE (10 Mg, 1x/day) (View Enalapril Maleate Review and Enalapril Maleate Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), NITROMEX (0.5 Mg, Unk) (View Nitromex Review and Nitromex Label ), FOLACIN (5 Mg, Unk) (View Folacin Review and Folacin Label ), ACETAMINOPHEN (500 Mg, Unk) (View Acetaminophen Review and Acetaminophen Label ), DUROFERON (100 Mg, Unk) (View Duroferon Review and Duroferon Label ). Patient was hospitalized.

6470083-6 | Diarrhoea, Hepatic Enzyme Increased
on Nov 26, 2009 Male patient from GERMANY , 79 years of age, weighting 216.1 lb, was diagnosed with cardiac failure, urinary tract infection (What is urinary tract infection?), type 2 diabetes mellitus, bedridden, prophylaxis against gastrointestinal ulcer, renal impairment, osteoarthritis (What is osteoarthritis?) and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, hepatic enzyme increased. Inspra dosage: 25 Mg, 1x/day. During the same period patient was treated with SIMVASTATIN (40 Mg, 1x/day) (View Simvastatin Review and Simvastatin Label ), AMOXICILLIN AND CLAVULANATE POTASSIUM (875 Mg Amoxicillin/125 Mg Clavulanic Acid) (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), INSUMAN COMB ^HOECHST MARION ROUSSEL^ (28/0/8 Iu/twice Daily) (View Insuman Comb ^hoechst Marion Roussel^ Review and Insuman Comb ^hoechst Marion Roussel^ Label ), KALINOR (1 Df, 2x/day) (View Kalinor Review and Kalinor Label ), EMBOLEX (3000 Iu, 1x/day) (View Embolex Review and Embolex Label ), OMEPRAZOLE (40 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), TORASEMIDE (100 Mg, 1x/day) (View Torasemide Review and Torasemide Label ), VOLTAREN DISPERS ^NOVARTIS^ (1-2 Tabs As Needed/week) (View Voltaren Dispers ^novartis^ Review and Voltaren Dispers ^novartis^ Label ). Patient was hospitalized.

6448623-2 | Arterial Thrombosis Limb, Blood Fibrinogen Increased, Bronchitis, Cardiac Failure, Condition Aggravated, Femoral Artery Occlusion, Gout, International Normalised Ratio Decreased, International Normalised Ratio Increased
on Nov 10, 2009 Male patient from FRANCE , 87 years of age, was diagnosed with cardiac failure, thrombosis prophylaxis, gout (What is gout?), type 2 diabetes mellitus, hypertension, hypokalaemia, dyspepsia and was treated with Inspra (View Usage). Patient had the following side effects: arterial thrombosis limb, blood fibrinogen increased, bronchitis (What is bronchitis?), cardiac failure, condition aggravated, femoral artery occlusion, gout (What is gout?), international normalised ratio decreased, international normalised ratio increased. Inspra dosage: 25 Mg, 1x/day. During the same period patient was treated with COUMADIN (3.75 Mg, 1x/day) (View Coumadin Review and Coumadin Label ), COLCHIMAX (1 Df, 1x/day) (View Colchimax Review and Colchimax Label ), GLUCOR (50 Mg, 3x/day) (View Glucor Review and Glucor Label ), RAMIPRIL (1 Df, 1x/day) (View Ramipril Review and Ramipril Label ), DIFFU K (1 Df, 1x/day) (View Diffu K Review and Diffu K Label ), CARBOSYMAG (1 Df, 3x/day) (View Carbosymag Review and Carbosymag Label ). Patient was hospitalized.

6434469-8 | Dyspnoea, Gastrointestinal Haemorrhage, Palpitations, Syncope
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: dyspnoea, gastrointestinal haemorrhage, palpitations, syncope on Oct 29, 2009 from IRELAND Additional patient health information: Male patient , 60 years of age, was diagnosed with diastolic dysfunction, ventricular hypertrophy and. Inspra dosage: 25 Mg, 1x/day. Patient was hospitalized.

6424928-6 | Hyperthyroidism, Thyroid Neoplasm
Adverse event was reported on Oct 22, 2009 by a Male patient taking Inspra (View Usage) (Dosage: 50 Mg, 1x/day) . Location: GERMANY , 58 years of age, Patient experienced the following unwanted or unexpected effects: hyperthyroidism, thyroid neoplasm.

6411302-1 | Cholestasis, Hepatitis
on Oct 13, 2009 Female patient from FRANCE , 56 years of age, was diagnosed with blood aldosterone, hypertension, diabetes mellitus, hypercholesterolaemia and was treated with Inspra (View Usage). Patient had the following side effects: cholestasis, hepatitis (What is hepatitis?). Inspra dosage: 25 Mg, 1x/day. During the same period patient was treated with INSULIN (Unk) (View Insulin Review and Insulin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), VALSARTAN AND HYDROCHLOROTHIAZIDE (View Valsartan And Hydrochlorothiazide Review and Valsartan And Hydrochlorothiazide Label ), IRBESARTAN (300 Mg, 1x/day) (View Irbesartan Review and Irbesartan Label ), ISOPTIN (120 Mg, 2x/day) (View Isoptin Review and Isoptin Label ).

6411262-3 | Hyperthyroidism, Thyroid Neoplasm
on Oct 13, 2009 Female patient from GERMANY , 58 years of age, was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: hyperthyroidism, thyroid neoplasm. Inspra dosage: 50 Mg, 1x/day.

6376617-4 | Dyspnoea, Gastrointestinal Haemorrhage, Palpitations, Syncope
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, gastrointestinal haemorrhage, palpitations, syncope on Sep 14, 2009 from IRELAND Additional patient health information: Female patient , 60 years of age, was diagnosed with diastolic dysfunction, ventricular hypertrophy and. Inspra dosage: 25 Mg, 1x/day. Patient was hospitalized.

6358369-7 | Haemorrhage Urinary Tract, Renal Failure Acute
Adverse event was reported on Sep 04, 2009 by a Female patient taking Inspra (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with cardiac failure, coronary artery disease (What is coronary artery disease?), hypertension, cardiac pacemaker insertion, oedema peripheral and. Location: GERMANY , 70 years of age, Patient had the following side effects: haemorrhage urinary tract, renal failure acute. During the same period patient was treated with ACETYLSALICYLIC ACID (100 Mg, 1x/day) (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), AQUAPHOR TABLET (10 Mg, 1x/day) (View Aquaphor Tablet Review and Aquaphor Tablet Label ), CLEXANE (80 Mg, 2x/day) (View Clexane Review and Clexane Label ), FURORESE (25 Mg, 2x/day) (View Furorese Review and Furorese Label ), RAMIPRIL (2.5 Mg, 1x/day) (View Ramipril Review and Ramipril Label ), BISOPROLOL (2.5 Mg, 1x/day) (View Bisoprolol Review and Bisoprolol Label ), DIGITOXIN (0.07 Mg, 1x/day) (View Digitoxin Review and Digitoxin Label ). Patient was hospitalized.

6348682-1 | Dermatitis, Dysphagia, Epiglottitis, Oropharyngeal Pain, Pemphigoid
on Aug 31, 2009 Female patient from GERMANY , 75 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: dermatitis, dysphagia, epiglottitis, oropharyngeal pain, pemphigoid. Inspra dosage: 25 Mg Daily. During the same period patient was treated with SIMVASTATIN (30 Mg, Daily) (View Simvastatin Review and Simvastatin Label ), MARCUMAR (Unk) (View Marcumar Review and Marcumar Label ), DELIX (10 Mg, Daily) (View Delix Review and Delix Label ), ASS RATIOPHARM (Unk) (View Ass-ratiopharm Review and Ass-ratiopharm Label ), BISOHEXAL (10 Mg, Daily) (View Bisohexal Review and Bisohexal Label ), TORASEMIDE (10 Mg, Unk) (View Torasemide Review and Torasemide Label ), PROVAS COMP (25 Mg/320 Mg 1x/day) (View Provas Comp Review and Provas Comp Label ), CLOPIDOGREL (75 Mg, Daily) (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

6343210-9 | Erythema, Rash Pruritic, Rash Pustular, Swelling Face
on Sep 08, 2009 Female patient from GERMANY , 61 years of age, was diagnosed with hypokalaemia, diabetes mellitus and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, rash pruritic, rash pustular, swelling face. Inspra dosage: 50 Mg, Daily. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ).

6322222-5 | Cholestasis, Cytolytic Hepatitis
Patient was taking Inspra (View Usage). Patient had the following side effects: cholestasis, cytolytic hepatitis on Aug 12, 2009 from FRANCE Additional patient health information: Female patient , 56 years of age, was diagnosed with blood aldosterone, diabetes mellitus, hypercholesterolaemia, hypertension and. Inspra dosage: 25 Mg, 1x/day. During the same period patient was treated with INSULIN (View Insulin Review and Insulin Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), COTAREG (View Cotareg Review and Cotareg Label ).

6307277-6 | Hallucination
Adverse event was reported on Aug 03, 2009 by a Female patient taking Inspra (View Usage) (Dosage: 25 Mg, 1x/day) was diagnosed with cardiac failure, dressler's syndrome and. Location: UNITED KINGDOM , 86 years of age, After Inspra was administered, patient had the following side effects: hallucination. During the same period patient was treated with LOSARTAN (100 Mg, 1x/day) (View Losartan Review and Losartan Label ), OMEPRAZOLE (20 Mg, 1x/day) (View Omeprazole Review and Omeprazole Label ), ATORVASTATIN (10 Mg, 1x/day) (View Atorvastatin Review and Atorvastatin Label ), BISOPROLOL (5 Mg, 1x/day) (View Bisoprolol Review and Bisoprolol Label ), ASPIRIN (75 Mg, 1x/day) (View Aspirin Review and Aspirin Label ).

6304325-4 | Blood Creatine Phosphokinase Increased, Pruritus
on Jul 30, 2009 Female patient from GERMANY , 67 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatine phosphokinase increased, pruritus. Inspra dosage: Unk.

6304023-7 | Blood Sodium Decreased, Breast Cancer, Confusional State, Dysphemia, Femur Fracture, Metastases To Bone, Speech Disorder
on Jul 09, 2009 Female patient from UNITED KINGDOM , 71 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Inspra (View Usage). Patient had the following side effects: blood sodium decreased, breast cancer (What is breast cancer?), confusional state, dysphemia, femur fracture, metastases to bone, speech disorder. Inspra dosage: 25 Mg, Unk. During the same period patient was treated with AROMASIN (View Aromasin Review and Aromasin Label ). Patient was hospitalized and became disabled.

6290975-0 | Dysphagia, Epiglottitis, Oropharyngeal Pain, Pemphigoid
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: dysphagia, epiglottitis, oropharyngeal pain, pemphigoid on Jul 21, 2009 from GERMANY Additional patient health information: Female patient , 75 years of age, was diagnosed with cardiac failure and. Inspra dosage: 1 Df, Daily.

6288797-X | Rash Pustular, Swelling Face
Adverse event was reported on Jul 21, 2009 by a Female patient taking Inspra (View Usage) (Dosage: 50 Mg, Daily) was diagnosed with hypokalaemia, diabetes mellitus and. Location: GERMANY , 61 years of age, Patient experienced the following unwanted or unexpected effects: rash pustular, swelling face. During the same period patient was treated with LANTUS (Unk) (View Lantus Review and Lantus Label ).

6288377-6 | Hallucination
on Jul 24, 2009 Female patient from UNITED KINGDOM , 90 years of age, was treated with Inspra (View Usage). Patient had the following side effects: hallucination. Inspra dosage: 25 Mg, Unk.

6275154-5 | Blood Sodium Decreased, Breast Cancer, Confusional State, Dysphemia, Femur Fracture, Metastases To Bone, Speech Disorder
on Jul 09, 2009 Female patient from UNITED KINGDOM , 71 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: blood sodium decreased, breast cancer (What is breast cancer?), confusional state, dysphemia, femur fracture, metastases to bone, speech disorder. Inspra dosage: 25 Mg, Unk. During the same period patient was treated with AROMASIN (View Aromasin Review and Aromasin Label ). Patient was hospitalized and became disabled.

6247411-X | Hepatotoxicity
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: hepatotoxicity on Jun 17, 2009 from GERMANY Additional patient health information: Female patient , 70 years of age, was diagnosed with myocardial infarction and. Inspra dosage: Unk. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), THYROID HORMONES (View Thyroid Hormones Review and Thyroid Hormones Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), TORASEMIDE (Unk) (View Torasemide Review and Torasemide Label ), DIGITALIS (Unk) (View Digitalis Review and Digitalis Label ). Patient was hospitalized.

6247224-9 | Blood Sodium Decreased, Breast Cancer, Confusional State, Dysphemia, Metastases To Bone
Adverse event was reported on May 18, 2009 by a Female patient taking Inspra (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED KINGDOM , 71 years of age, Patient had the following side effects: blood sodium decreased, breast cancer (What is breast cancer?), confusional state, dysphemia, metastases to bone. During the same period patient was treated with AROMASIN (View Aromasin Review and Aromasin Label ).

6246610-0 | Acute Prerenal Failure, Blood Creatinine Increased, Dehydration, Gastroenteritis, Urinary Tract Infection
on Jun 16, 2009 Female patient from GERMANY , 51 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: acute prerenal failure, blood creatinine increased, dehydration, gastroenteritis (What is gastroenteritis?), urinary tract infection (What is urinary tract infection?). Inspra dosage: . During the same period patient was treated with XIPAMIDE (View Xipamide Review and Xipamide Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), BENALAPRIL (View Benalapril Review and Benalapril Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ). Patient was hospitalized.

6245345-8 | Abnormal Loss Of Weight, Asthenia, Decreased Appetite, Renal Failure
on Jun 16, 2009 Female patient from FRANCE , 76 years of age, was diagnosed with cardiac failure and was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: abnormal loss of weight, asthenia, decreased appetite, renal failure. Inspra dosage: 0.5 Df, Alternate Day. During the same period patient was treated with BUMEX (1 Df, Alternate Day) (View Bumex Review and Bumex Label ).

6244623-6 | Blood Creatine Phosphokinase Increased, Pruritus
Patient was taking Inspra (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, pruritus on Jun 15, 2009 from GERMANY Additional patient health information: Female patient , 67 years of age, was diagnosed with cardiac failure and. Inspra dosage: Unk.

6236127-1 | Hallucination
Adverse event was reported on Jun 09, 2009 by a Female patient taking Inspra (View Usage) (Dosage: 25 Mg, Unk) . Location: UNITED KINGDOM , 90 years of age, After Inspra was administered, patient had the following side effects: hallucination.

6214638-2 | Food Aversion, Hallucination
on May 25, 2009 Female patient from GERMANY , 86 years of age, was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: food aversion, hallucination. Inspra dosage: Unk. During the same period patient was treated with FUROSEMID (View Furosemid Review and Furosemid Label ).

6204775-0 | Blood Sodium Decreased, Breast Cancer, Confusional State, Dysphemia, Metastases To Bone
on May 18, 2009 Female patient from UNITED KINGDOM , 71 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Inspra (View Usage). Patient had the following side effects: blood sodium decreased, breast cancer (What is breast cancer?), confusional state, dysphemia, metastases to bone. Inspra dosage: . During the same period patient was treated with AROMASIN (View Aromasin Review and Aromasin Label ).

6194632-0 | Arterial Thrombosis Limb, Blood Creatinine Increased, Blood Potassium Increased, Intermittent Claudication, Necrosis, Peripheral Vascular Disorder, Thrombocytopenia
Patient was taking Inspra (View Usage). After Inspra was administered, patient had the following side effects: arterial thrombosis limb, blood creatinine increased, blood potassium increased, intermittent claudication, necrosis, peripheral vascular disorder, thrombocytopenia on May 19, 2009 from GERMANY Additional patient health information: Female patient , 68 years of age, was diagnosed with cardiac failure and. Inspra dosage: 25 Mg, 1x/day. Patient was hospitalized.

6185572-1 | Hepatotoxicity
Adverse event was reported on Apr 29, 2009 by a Female patient taking Inspra (View Usage) (Dosage: Unk) was diagnosed with myocardial infarction and. Location: GERMANY , 70 years of age, Patient experienced the following unwanted or unexpected effects: hepatotoxicity. During the same period patient was treated with MARCUMAR (View Marcumar Review and Marcumar Label ), THYROID HORMONES (View Thyroid Hormones Review and Thyroid Hormones Label ), SIMVASTATIN (Unk) (View Simvastatin Review and Simvastatin Label ), BISOPROLOL (Unk) (View Bisoprolol Review and Bisoprolol Label ), TORASEMIDE (Unk) (View Torasemide Review and Torasemide Label ), DIGITALIS (Unk) (View Digitalis Review and Digitalis Label ). Patient was hospitalized.

5974919-4 | Arterial Thrombosis Limb, Blood Creatinine Increased, Blood Potassium Increased, Intermittent Claudication, Thrombocytopenia
on Nov 27, 2008 Male patient from GERMANY , 68 years of age, was treated with Inspra (View Usage). Patient had the following side effects: arterial thrombosis limb, blood creatinine increased, blood potassium increased, intermittent claudication, thrombocytopenia. Inspra dosage: .

5967500-4 | Swelling Face
on Nov 17, 2008 Male patient from NETHERLANDS , weighting 189.6 lb, was diagnosed with oedema, cardiac failure and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: swelling face. Inspra dosage: .

5960552-7 | Abdominal Pain, Chest Pain, Fatigue, Headache, Herpes Zoster, Hypertension, Hypoaesthesia, Insomnia, Joint Swelling
Patient was taking Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), chest pain (What is chest pain?), fatigue, headache (What is headache?), herpes zoster, hypertension, hypoaesthesia, insomnia, joint swelling on Nov 11, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 244.1 lb, was diagnosed with hyperaldosteronism and. Inspra dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), GARLIC (View Garlic Review and Garlic Label ), FLAXSEED OIL (View Flaxseed Oil Review and Flaxseed Oil Label ), ONE A DAY (View One-a-day Review and One-a-day Label ), VITAMINS (View Vitamins Review and Vitamins Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ).

5949024-3 | Chest Discomfort, Tachycardia, Vertigo
Adverse event was reported on Oct 30, 2008 by a Female patient taking Inspra (View Usage) (Dosage: ) was diagnosed with cardiomyopathy (What is cardiomyopathy?) and. Location: FRANCE , weighting 138.9 lb, Patient had the following side effects: chest discomfort, tachycardia, vertigo. During the same period patient was treated with BURINEX (View Burinex Review and Burinex Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), COVERSYL (View Coversyl Review and Coversyl Label ).

5903740-8 | Chest Pain, Fatigue, Headache, Herpes Zoster, Hypertension, Hypoaesthesia, Insomnia, Joint Swelling
on Sep 19, 2008 Male patient from UNITED STATES , 41 years of age, weighting 241.5 lb, was diagnosed with primary hyperaldosteronism and was treated with Inspra (View Usage). After Inspra was administered, patient had the following side effects: chest pain (What is chest pain?), fatigue, headache (What is headache?), herpes zoster, hypertension, hypoaesthesia, insomnia, joint swelling. Inspra dosage: . During the same period patient was treated with CLONIDINE (View Clonidine Review and Clonidine Label ), GARLIC (View Garlic Review and Garlic Label ), FLAXSEED OIL (View Flaxseed Oil Review and Flaxseed Oil Label ), ONE A DAY (View One-a-day Review and One-a-day Label ), VITAMINS (View Vitamins Review and Vitamins Label ).

5867915-9 | Vomiting
on Aug 22, 2008 Male patient from GERMANY , 71 years of age, was treated with Inspra (View Usage). Patient experienced the following unwanted or unexpected effects: vomiting. Inspra dosage: . Patient was hospitalized.

5853395-6 | Abdominal Pain Upper, Balance Disorder, Coordination Abnormal, Dizziness, Emotional Distress, Nasopharyngitis
Patient was taking Inspra (View Usage). Patient had the following side effects: abdominal pain upper, balance disorder, coordination abnormal, dizziness (What is dizziness?), emotional distress, nasopharyngitis on Aug 11, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 136.0 lb, was diagnosed with ventricular arrhythmia, hypertension, cardiac failure congestive and. Inspra dosage: Daily Dose:25mg-text:25 Mg-freq:once Daily. During the same period patient was treated with AMIODARONE (View Amiodarone Review and Amiodarone Label ), COREG (View Coreg Review and Coreg Label ), COZAAR (View Cozaar Review and Cozaar Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).